Genmab — Juli 2015
-
vi har ikke godt af alle de penge
-
Hold da op markedet er tyndt i dag
-
Der handles næsten ingen aktier
-
vi er på vej mod 700. 692 nu
-
Ja ikke noget ændret der
-
Det er lidt ærgerligt der ikke er mere omsætning. Så ville det ligne et short squeeze. http://traderhq.com/understanding-short-squeeze-and-how-to-profit/
-
Foreløbig beslutning fra NICE: Idelalisib, in combination with rituximab, is not recommended. https://www.nice.org.uk/guidance/GID-TAG488/documents/leukaemia-chronic-lymphocytic-previously-treated-idelalisib-id764-appraisal-consultation-document2
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
